PMON71 Evaluation of a new transition organization for young adults with endocrine or metabolic diseases

Objective To evaluate the effect of a new care organisation on outcomes of transition success Design. Non-randomized controlled trial in a French University Hospital. Methods Patients transferred to adult care during the control period (04/2014-08/2016) and the intervention period (09/2016-06/2018) were included. The intervention is based on case management involving liaising with pediatric services, personalising care pathways, and liaising with structures outside hospital (general practitioner, educational and social sector). Results 202 patients were included (101 per period), the most represented pathologies were congenital and non-congenital hypopituitarism (respectively n=34 (17%) and n=45 (22%)) and thyroid diseases (n=21, 10%). Patients were aged 22.5 in median at 24 months post transfer where 12 were lost to follow up in the control group versus 9 with the intervention (p=0.49). The percentage of honoured consultation among those planned during 24 months was higher with intervention (p=0.0065). Patient satisfaction, physician trust, transfer delay did not differ between the groups. The incremental cost-effectiveness ratio was €179 per patient not lost to follow-up. Conclusions At 24 months post transfer the rate of lost to follow-up does not differ significantly, but indicators of a steadier follow-up are increased and the intervention appears to be cost-effective. Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.